CAS: 2091134-35-7
Marca | Dados do produto | Pureza | Gama de preços | Estimativa de entrega |
---|---|---|---|---|
(αR,3R)-N-[3-[5-Fluoro-2-[(3-methoxy-1-methyl-1H-pyrazol-4-yl)amino]-4-pyrimidinyl]-1H-indol-7-yl]-α,3,4-trimethyl-1-piperazineaceta mide REF: 3D-RID13435CAS: 2091134-35-7 | Min. 95% | A consultar | Ter 18 Fev 25 | |
JAK1-IN-4 REF: TM-T15606CAS: 2091134-35-7 | 98% | 1.000,00 €~2.617,00 € | Ter 25 Fev 25 |
(αR,3R)-N-[3-[5-Fluoro-2-[(3-methoxy-1-methyl-1H-pyrazol-4-yl)amino]-4-pyrimidinyl]-1H-indol-7-yl]-α,3,4-trimethyl-1-piperazineaceta mide
CAS:2091134-35-7
(αR,3R)-N-[3-[5-Fluoro-2-[(3-methoxy-1-methyl-1H-pyrazol-4-yl)amino]-4-pyrimidinyl]-1H-indol-7-yl]-α,3,4-trimethyl-1 -piperazineaceta mide is a peptide with the sequence N-(3-[5fluoro2[(3methoxy1methyl1Hpyrazol4yl)amino]4pyrimidinyl]-1Hindol7yl)α34trimethylpiperazineacetamide. It is an activator of …
Fórmula:
C26H32FN9O2
Pureza:
Min. 95%
Peso molecular:
521.6 g/mol
Ref: 3D-RID13435
5mg | A consultar | ||
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar |
Entrega estimada em Estados Unidos, Terça-feira 18 de Fevereiro de 2025
JAK1-IN-4
CAS:2091134-35-7
JAK1-IN-4 selectively blocks JAK1 (IC50 = 85 nM) over JAK2/JAK3 and halts STAT3 phosphorylation in …
Fórmula:
C26H32FN9O2
Pureza:
98%
Cor e Forma:
Solid
Peso molecular:
521.59
Ref: TM-T15606
25mg | 1.549,00 € | ||
50mg | 2.038,00 € | ||
100mg | 2.617,00 € |
Entrega estimada em Estados Unidos, Terça-feira 25 de Fevereiro de 2025